Hong Kong Stock Movement: GF HEALTHCARE fell 18.18%
GF HEALTHCARE fell 18.18%; Baize Medical fell 9.46%, with a transaction volume of HKD 2.282 billion; Haijia Medical fell 1.47%, with a transaction volume of HKD 141 million; China Resources Medical rose 0.27%, with a transaction volume of HKD 17.95 million; Shengbeila fell 4.90%, with a market value of HKD 4.106 billion
Hong Kong Stock Movement
Stocks with High Trading Volume in the Industry
Haijia Medical fell 1.47%, with a trading volume of HKD 141 million. Based on recent key news:
-
On September 15, Zhongtai International stated that the control of medical insurance costs continues to impact the performance of traditional medical service companies in Hong Kong, with Haijia Medical's profits declining year-on-year. Nevertheless, the government has repeatedly introduced policies to alleviate the funding issues of medical institutions, and the operating environment is expected to gradually improve in the future.
-
On September 15, the Trump administration announced it would strengthen scrutiny of licensing deals for innovative drugs from China, attempting to block experimental therapies invented in China. This move may have a short-term impact on Chinese pharmaceutical companies' licensing deals overseas.
-
On September 15, Zhongtai International believes that as the immediate settlement of medical insurance gradually takes effect in various regions and the introduction of commercial insurance innovative drug catalogs, the operating environment for leading medical institutions is expected to gradually improve. There is an increase in demand for innovative drugs, influenced by medical insurance policies
